Clinical Trial Update: Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients [Phase 3]

View source ↗

Summary

Ongoing Phase 3 trial evaluating the efficacy and safety of masitinib versus placebo in patients with amyotrophic lateral sclerosis; the study status is recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Masitinib (masitinib)

Snippet

Sponsor: AB Science | Conditions: Amyotrophic Lateral Sclerosis | Phase 3 | Status: RECRUITING